ATXA Therapeutics Founder and CSO, Prof Therese Kinsella will represent the company at an event on the European Innovation Council Funding Opportunities for Breakthrough Innovation. This event is hosted by the European Commission Representation in Ireland and will take place on Friday 3rd May 2019.
The European Innovation Council (EIC) will offer €2bn for the financing of disruptive, market-creating innovation in its pilot phase between 2019-2020, in view of setting up a fully-fledged EIC under the next EU budget (2021-2027).
